Holen Sie sich die Stockscreener-App
1.70
3.03%
0.05
Vorhandelsmarkt:
1.64
-0.06
-3.53%
Schlusskurs vom Vortag:
$1.65
Offen:
$1.62
24-Stunden-Volumen:
38,801
Relative Volume:
0.80
Marktkapitalisierung:
$9.40M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.29M
KGV:
-0.4261
EPS:
-3.99
Netto-Cashflow:
$-12.27M
1W Leistung:
+2.41%
1M Leistung:
-5.56%
6M Leistung:
-55.61%
1J Leistung:
-50.00%
1-Tages-Spanne:
$1.62
$1.72
1-Wochen-Bereich:
$1.55
$1.83
52-Wochen-Spanne:
$1.412
$5.01
Aprea Therapeutics Inc Stock (APRE) Company Profile
Firmenname
Aprea Therapeutics Inc
Sektor
Branche
Telefon
215-948-4119
Adresse
3805 OLD EASTON ROAD, DOYLESTOWN, MA
Vergleichen Sie APRE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
APRE
Aprea Therapeutics Inc
|
1.70 | 9.07M | 0 | -14.29M | -12.27M | -3.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Aprea Therapeutics Inc Stock (APRE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-12-28 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-12-16 | Eingeleitet | Berenberg | Buy |
| 2020-09-29 | Fortgesetzt | JP Morgan | Neutral |
| 2020-06-22 | Eingeleitet | H.C. Wainwright | Neutral |
| 2020-04-21 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2019-10-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-10-28 | Eingeleitet | RBC Capital Mkts | Outperform |
Alle ansehen
Aprea Therapeutics Inc Aktie (APRE) Neueste Nachrichten
Is Aprea Therapeutics Inc. Stock Overbought or Oversold RSI Indicator AnalysisFree Real Time Trade Opportunity Alerts - Newser
Is it too late to sell Aprea Therapeutics Inc.Daily Pattern Analysis with Return Forecast - Newser
Analyzing drawdowns of Aprea Therapeutics Inc. with statistical toolsStock Market Trend and Pattern Analysis - Newser
How hedge fund analytics apply to Aprea Therapeutics Inc. stockTop Stock Picks with Forecast Accuracy - Newser
Long term hold vs stop loss in Aprea Therapeutics Inc.Predictive AI Engine for Smart Investing - Newser
Combining price and volume data for Aprea Therapeutics Inc.Predictable Income Summary for Long-Term Trades - Newser
Signal strength of Aprea Therapeutics Inc. stock in tech scannersFree Consistent Profit Pattern Recognition Tools - Newser
Multi asset correlation models including Aprea Therapeutics Inc.Entry Confirmation Based on Volatility Analysis - Newser
What candlestick patterns are forming on Aprea Therapeutics Inc.Free Early Entry Tips With Low Risk Zone - Newser
Aprea Therapeutics (APRE) to Release Quarterly Earnings on Monday - Defense World
How to interpret RSI for Aprea Therapeutics Inc. stockFree Fundamental + Technical Hybrid Stock Tips - Newser
Is Aprea Therapeutics Inc. forming a bottoming baseLong-Term Safety Investment Analysis Report - Newser
Strategies to average down on Aprea Therapeutics Inc.Swing Reversal Forecast Based on Patterns - Newser
Aprea Therapeutics APRE 2025Q2 Earnings Preview Upside Potential Amid Breakthrough Therapy Designation - AInvest
Key resistance and support levels for Aprea Therapeutics Inc.Buy Opportunity Forecast for Fast Traders - Newser
Aprea Therapeutics Inc. stock retracement – recovery analysisSmart Risk Strategy with Entry Optimization - Newser
Applying Wyckoff theory to Aprea Therapeutics Inc. stockTrading Opportunities Forecast by AI Insight - Newser
How to forecast Aprea Therapeutics Inc. trends using time seriesReal Time Stock Movement and Alerts - Newser
Trend analysis for Aprea Therapeutics Inc. this week3-Day Market Movement Forecast Analysis - Newser
How Aprea Therapeutics Inc. stock performs during market volatilityBuy and Hold Return Summary with Charts - Newser
Why Aprea Therapeutics Inc. stock attracts strong analyst attentionFree Real Time Trade Opportunity Alerts - Newser
Is Aprea Therapeutics Inc. meeting your algorithmic filter criteriaTrading Watchlist with Real Time Filters - Newser
Quantitative breakdown of Aprea Therapeutics Inc. recent moveAutomated AI Forecast with Trading Alerts - Newser
Real time social sentiment graph for Aprea Therapeutics Inc.Risk Aware Swing Trade Analysis Insights - Newser
Key metrics from Aprea Therapeutics Inc.’s quarterly dataWeekly Chart Watchlist with Trade Guidance - Newser
Published on: 2025-08-04 00:37:06 - Newser
What is Aprea Therapeutics Inc. company’s growth strategyDynamic investment growth - Jammu Links News
What is the risk reward ratio of investing in Aprea Therapeutics Inc. stockInvest smarter with actionable stock recommendations - Jammu Links News
What catalysts could drive Aprea Therapeutics Inc. stock higher in 2025Lightning-fast capital gains - Jammu Links News
What analysts say about Aprea Therapeutics Inc. stockHigh-return market picks - Jammu Links News
Published on: 2025-08-04 04:57:29 - Jammu Links News
What are analysts’ price targets for Aprea Therapeutics Inc. in the next 12 monthsAchieve exceptional returns with expert guidance - Jammu Links News
Why is Aprea Therapeutics Inc. stock attracting strong analyst attentionSky-high profits - Jammu Links News
What are the latest earnings results for Aprea Therapeutics Inc.Rapid return acceleration - Jammu Links News
Finanzdaten der Aprea Therapeutics Inc-Aktie (APRE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):